Pharmaceutical Industry

Drug Development Research and Development Drug Manufacturing Manufacturing Drug Pricing Innovation Clinical Trials Drug Discovery Generic Medicines Vaccine Development

AstraZeneca Buys Stake in Summit to Pursue Cancer Drug Combinations

The equity purchase funds a research pact to test ivonescimab with AstraZeneca’s cancer medicines to speed combination trials.

Pharma Dividend Trade-Off: Pfizer's High Yield Versus AbbVie's Durability and Lilly's Growth

India Gives Regulators Power to Debar Firms for Fabricated Drug Data

Encube Ethicals Founder Buys ₹106.52 Crore Sea‑Facing Apartment in Juhu

GSK to Close Stevenage Hub and Build £400m Cambridge R&D Centre

Pakistan Panel Approves Prices for 52 Life‑Saving Medicines

Bristol Myers Squibb Buys Second NVIDIA DGX SuperPOD Built on Vera Rubin

Mexico Launches Consolidated Tender for 2027–28 Medicines Limited to Free‑Trade Partners

Takeda Signs $600 Million‑Value AI Drug Discovery Deal With Insilico

Health Ministry Proposes 12‑Month Minimum Shelf Life and Faster Import Route for Small Research Shipments

Insilico and SK Biopharmaceuticals Sign $2.5 Billion AI Drug Discovery Deal for Neuroimmune Therapies

Moderna Signals Interest in Buying Biontech's German Plants

First Patient Dosed in Human Trial for Cell 'Rejuvenation' Therapy

Eli Lilly and Boehringer Cut Planned Germany Investments, Signalling Risk to Pharma Hub

Court Orders Drogasil to Stop Tying Discounts to CPF and Pay R$10 Million

Bristol Myers Squibb to Deploy Anthropic’s Claude Across Global Operations

Bristol Myers and Hengrui Ink Up to $15.2 Billion Drug Discovery Alliance

SICC Pledges C$2 Billion Drug Ingredients Plant in Hidalgo Under MoU

BioNTech Faces Worker Pushback Over Site Closures Threatening 1,860 Jobs

Pfizer Tops Q1 Forecasts on Eliquis Strength, Reaffirms 2026 Outlook